![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Kller Marcus D
Publisher: Informa Healthcare
ISSN: 1746-0441
Source: Expert Opinion on Drug Discovery, Vol.3, Iss.3, 2008-03, pp. : 329-342
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Targeted treatment for rheumatoid arthritis
Inpharma, Vol. 1, Iss. 1424, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
B Cell-Targeted Therapy for Rheumatoid Arthritis: An Update on the Evidence
Drugs, Vol. 66, Iss. 5, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Biologic Therapy in Rheumatoid Arthritis
Current Topics in Medicinal Chemistry, Vol. 13, Iss. 6, 2013-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)